• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】60587

【品名】dimethyl 2-oxo-3-[3-(trifluoromethyl)phenyl]propylphosphonate

【CA登记号】

【 分 子 式 】C12H14F3O4P

【 分 子 量 】310.2097316

【元素组成】C 46.46% H 4.55% F 18.37% O 20.63% P 9.98%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(IX)

[3-(Trifluoromethyl)phenyl]acetic acid (VI) is coupled to N,O-dimethylhydroxylamine to produce the N-methoxy amide (VII). Subsequent condensation of methoxyamide (VII) with dimethyl methylphosphonate (VIII) in the presence of BuLi leads to the oxo phosphonate (IX). Horner-Emmons condensation of phosphonate (IX) with aldehyde (V) furnishes enone (X). Diastereoselective reduction of (X) by means of catecholborane in the presence of (R)-2-methyl-CBS-oxazaborolidine in cold CH2Cl2 provides the allylic alcohol (XI) as the major isomer. Subsequent catalytic hydrogenation of (XI) gives the saturated alcohol (XII). Finally, basic hydrolysis of the ethyl ester group of (XII) produces the target carboxylic acid

1 Cameron, K.O.; Crawford, D.T.; DaSilva-Jardine, P.; et al.; Discovery and bone anabolic activity of highly selective EP4 receptor prostaglandin E2 (PGE2) agonists. 224th ACS Natl Meet (Aug 18 2002, Boston) 2002, Abst MEDI 307.
2 Thompson, D.D.; Lefker, B.A.; Cameron, K.O.; Ke, H.Z. (Pfizer Products Inc.); EP4 receptor selective agonists in the treatment of osteoporosis. EP 1110949; JP 2001181210; WO 0146140 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 60584 ethyl 7-[(2R)-2-formyl-5-oxopyrrolidinyl]heptanoate C14H23NO4 详情 详情
(VI) 60585 2-[3-(trifluoromethyl)phenyl]acetic acid C9H7F3O2 详情 详情
(VII) 60586 N-methoxy-N-methyl-2-[3-(trifluoromethyl)phenyl]acetamide C11H12F3NO2 详情 详情
(VIII) 13607 dimethyl methylphosphonate 756-79-6 C3H9O3P 详情 详情
(IX) 60587 dimethyl 2-oxo-3-[3-(trifluoromethyl)phenyl]propylphosphonate C12H14F3O4P 详情 详情
(X) 60588 ethyl 7-((5R)-2-oxo-5-{(E)-3-oxo-4-[3-(trifluoromethyl)phenyl]-1-butenyl}pyrrolidinyl)heptanoate C24H30F3NO4 详情 详情
(XI) 60589 ethyl 7-((2R)-2-{(E,3S)-3-hydroxy-4-[3-(trifluoromethyl)phenyl]-1-butenyl}-5-oxopyrrolidinyl)heptanoate C24H32F3NO4 详情 详情
(XII) 60590 ethyl 7-((2S)-2-{(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenyl]butyl}-5-oxopyrrolidinyl)heptanoate C24H34F3NO4 详情 详情

合成路线2

该中间体在本合成路线中的序号:(VII)

 

1 Gutman A, Nisnevich G, Etinger M, et aL. 2005. Process for the preparation of prostaglandin derivatives. U S Pat Appl Publ. Cont-in-part of U S Ser N0478 849. US 2005209337(本专利属于Finetech Laboratories Ltd, Israel)
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10146 Epichlorohydrin; 2-(Chloromethyl)oxirane 106-89-8 C3H5ClO 详情 详情
(III) 66881 1-chloro-3-(3-(trifluoromethyl)phenyl)propan-2-ol 6310-15-2 C10H10ClF3O 详情 详情
(IV) 66882 1-chloro-3-(3-(trifluoromethyl)phenyl)propan-2-one   C10H8ClF3O 详情 详情
(V) 66883 (Z)-2-(1-chloro-3-(3-(trifluoromethyl)phenyl)propan-2-ylidene)hydrazinecarboxamide   C11H11ClF3N3O 详情 详情
(VI) 66884 (Z)-dimethyl (2-(2-carbamoylhydrazono)-3-(3-(trifluoromethyl)phenyl)propyl)phosphonate   C13H17F3N3O4P 详情 详情
(VII) 60587 dimethyl 2-oxo-3-[3-(trifluoromethyl)phenyl]propylphosphonate C12H14F3O4P 详情 详情
(VIII) 43178 (3aR,4S,5R,6aS)-4-(hydroxymethyl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate 31752-99-5 C21H20O5 详情 详情
(IX) 32122 (3aR,4R,5R,6aS)-2-oxo-4-[(E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]hexahydro-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate C31H25F3O6 详情 详情
(X) 66885     C27H34O5Si 详情 详情
(XI) 66886 (3aR,4R,5R,6aS)-5-hydroxy tert-butyldimethylsilyl-4-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]hexahydro-2H-cyclopenta[b]furan-2-one   C24H37F3O5Si 详情 详情
(XII) 66887 (Z)-7-((1S,3S,5R)-2-((E)-3-((tert-butyldimethylsilyl)oxy)-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoic acid   C29H43F3O5Si 详情 详情
(XIII) 66888 (Z)-7-((1S,3S,5R)-3,5-dihydroxy-2-((E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoic acid   C23H29F3O6 详情 详情
33504 (II) 33504 3-(trifluoromethyl)phenol 98-17-9 C7H5F3O 详情 详情
Extended Information